WIC
GILD icon

WealthBridge Investment Counsel’s Gilead Sciences GILD Stock Holding History

WealthBridge Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.04M Sell
63,605
-200
-0.3% -$26.4K 2.15% 20
2026
Q1 		$8.89M Sell
63,805
-525
-0.8% -$73.5K 2.71% 15
2025
Q4 		$7.9M Sell
64,330
-100
-0.2% -$12.2K 2.37% 21
2025
Q3 		$7.15M Sell
64,430
-525
-0.8% -$59.7K 2.2% 22
2025
Q2 		$7.2M Sell
64,955
-4,450
-6% -$474K 2.34% 17
2025
Q1 		$7.78M Sell
69,405
-800
-1% -$82.5K 2.83% 17
2024
Q4 		$6.49M Sell
70,205
-400
-0.6% -$36K 2.38% 21
2024
Q3 		$5.92M Sell
70,605
-350
-0.5% -$26.7K 2.1% 27
2024
Q2 		$4.87M Sell
70,955
-3,100
-4% -$207K 1.86% 28
2024
Q1 		$5.42M Sell
74,055
-3,250
-4% -$250K 2.01% 28
2023
Q4 		$6.26M Sell
77,305
-850
-1% -$66.1K 2.5% 20
2023
Q3 		$5.86M Sell
78,155
-250
-0.3% -$19.2K 2.55% 20
2023
Q2 		$6.04M Buy
78,405
+200
+0.3% +$16K 2.54% 19
2023
Q1 		$6.49M Sell
78,205
-850
-1% -$70.4K 2.87% 15
2022
Q4 		$6.79M Buy
79,055
+1,700
+2% +$135K 2.97% 14
2022
Q3 		$4.77M Buy
77,355
+3,300
+4% +$208K 2.51% 21
2022
Q2 		$4.58M Sell
74,055
-800
-1% -$49.5K 2.32% 24
2022
Q1 		$4.45M Sell
74,855
-260
-0.3% -$16.6K 1.96% 28
2021
Q4 		$5.45M Buy
75,115
+1,300
+2% +$89.5K 2.31% 23
2021
Q3 		$5.16M Sell
73,815
-100
-0.1% -$7.03K 2.32% 23
2021
Q2 		$5.09M Buy
73,915
+2,750
+4% +$184K 2.25% 22
2021
Q1 		$4.6M Buy
71,165
+250
+0.4% +$16.1K 2.25% 23
2020
Q4 		$4.13M Buy
70,915
+6,400
+10% +$386K 2.16% 23
2020
Q3 		$4.08M Buy
64,515
+1,075
+2% +$74.5K 2.48% 19
2020
Q2 		$4.88M Buy
63,440
+700
+1% +$53.6K 3.24% 13
2020
Q1 		$4.69M Buy
62,740
+1,500
+2% +$104K 3.98% 11
2019
Q4 		$3.98M Buy
+61,240
New +$3.99M 2.26% 20

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WealthBridge Investment Counsel's GILD Position: Q2 2026 in Review

WealthBridge Investment Counsel reduced its Gilead Sciences (GILD) stake by 0.31% in Q2 2026, selling an estimated $26.4K and leaving 63,605 shares worth $8.04M. The position accounts for 2.15% of the portfolio, ranked #20.

WealthBridge Investment Counsel first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.89M in Q1 2026. 1,051 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WealthBridge Investment Counsel held 63,605 shares of Gilead Sciences worth $8.04M as of Q2 2026.
  • WealthBridge Investment Counsel sold 200 Gilead Sciences shares in Q2 2026, an estimated $26.4K.
  • Gilead Sciences made up 2.15% of WealthBridge Investment Counsel's portfolio in Q2 2026, its #20 holding.
  • WealthBridge Investment Counsel first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • WealthBridge Investment Counsel's Gilead Sciences position peaked at $8.89M in Q1 2026.
  • 1,051 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WealthBridge Investment Counsel's 13F filing for Q2 2026, filed 15 Jul 2026.